Advaite, an innovative biotech company focused on developing novel diagnostics, announced today that it will begin supplying the global market with its COVID-19 rapid response diagnostic testing kits, ADVAITE RAPCOV, to help efforts to contain the spread of COVID-19 virus infection. This diagnostic test kit was developed in collaboration with Dr. Jun Xing, Windsor, Canada using a proprietary technology (US IP pending). In light of the emergence of this pathogen (COVID-19 virus) and its impact on public health, there is an urgent and unmet need to identify patients who may be carrying the virus.
